Q2 2026 Holdings
Filed 2026-08-14 | 42 holdings | $529.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abivax SA(ABVX)Call | SPONSORED ADS | 00370M103 | $53.3M | 400,000 | 10.1% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $31.3M | 1,700,000 | 5.9% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $27.2M | 204,314 | 5.1% |
| Immunitybio Inc(IBRX)Put | COM | 45256X103 | $26.3M | 3,000,800 | 5.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $25.8M | 600,836 | 4.9% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $24.9M | 4,215,930 | 4.7% |
| Alumis Inc(ALMS) | COM | 022307102 | $24.1M | 856,061 | 4.6% |
| Sol-Gel Technologies LTD(SLGL) | SHS NEW | M8694L137 | $20.3M | 274,363 | 3.8% |
| Ultragenyx Pharmaceutical in(RARE)Put | COM | 90400D108 | $20.0M | 600,000 | 3.8% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $20.0M | 425,000 | 3.8% |
| Annexon Inc(ANNX) | COM | 03589W102 | $20.0M | 3,500,000 | 3.8% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $17.4M | 183,330 | 3.3% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $16.7M | 855,813 | 3.1% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $15.7M | 2,029,933 | 3.0% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $15.1M | 921,481 | 2.9% |
| Immix Biopharma Inc(IMMX) | COM | 45258H106 | $13.2M | 1,277,642 | 2.5% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $13.0M | 1,000,000 | 2.5% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $12.6M | 700,000 | 2.4% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $12.2M | 175,000 | 2.3% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $11.1M | 352,180 | 2.1% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $10.3M | 317,221 | 1.9% |
| Opus Genetics Inc(IRD) | COM | 67577R102 | $8.1M | 1,970,187 | 1.5% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $7.9M | 1,200,000 | 1.5% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $7.7M | 109,603 | 1.5% |
| Inflarx NV(IFRX) | COM | N44821101 | $6.8M | 3,046,557 | 1.3% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $5.8M | 842,106 | 1.1% |
| Jatt II Acquisition Corp | ORD SHS | G50765109 | $5.7M | 500,000 | 1.1% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $5.5M | 300,000 | 1.0% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $5.3M | 1,741,232 | 1.0% |
| Amanat Acquisition Corp | CL A ORD | G0375M101 | $5.1M | 500,000 | 1.0% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $4.9M | 951,809 | 0.9% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $4.9M | 450,000 | 0.9% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $4.8M | 2,284,819 | 0.9% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $4.3M | 325,000 | 0.8% |
| Scynexis Inc(SCYX) | COM | 811292309 | $3.8M | 944,292 | 0.7% |
| Galectin Therapeutics Inc(GALT)Call | COM NEW | 363225202 | $3.7M | 800,000 | 0.7% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $3.6M | 70,000 | 0.7% |
| Humacyte Inc(HUMA) | COM | 44486Q103 | $2.9M | 3,750,000 | 0.6% |
| Rein Therapeutics Inc(RNTX) | COM NEW | 00887A204 | $2.7M | 2,575,000 | 0.5% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $2.6M | 156,906 | 0.5% |
| Anavex Life Sciences Corp(AVXL)Call | COM NEW | 032797300 | $1.4M | 521,300 | 0.3% |
| Promis Neurosciences Inc(PMN) | COM SHS | 74346M505 | $1.1M | 86,150 | 0.2% |